Inventor · disambiguated record
Neeraj Jagdish Agrawal
Also filed as: AGRAWAL NEERAJ · AGRAWAL NEERAJ J · AGRAWAL NEERAJ JAGDISH
18 granted patents·14 pending applications·65 citations·filing 2013–2025
92Inventor score
Top patents by PatentIndex Score
32 records- 0193US11530274B2Anti-STEAP1 antigen-binding proteinAMGEN INC·Filed 2019·Granted Dec 20, 2022·8 cites·72 claims
- 0292US10851144B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2016·Granted Dec 1, 2020·16 cites·10 claims
- 0391US11891435B2Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereofAMGEN INC·Filed 2021·Granted Feb 6, 2024·1 cites·24 claims
- 0491US11541103B2Interleukin-21 mutein/ anti-PD-1 antibody conjugatesAMGEN INC·Filed 2018·Granted Jan 3, 2023·7 cites·34 claims
- 0591US10738110B2PAC1 antibodies and uses thereofAMGEN INC·Filed 2019·Granted Aug 11, 2020·3 cites·17 claims
- 0691US10294303B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2016·Granted May 21, 2019·12 cites·14 claims
- 0787US11518808B2Anti-PD-1 antibodies and methods of treatmentAMGEN INC·Filed 2019·Granted Dec 6, 2022·5 cites·21 claims
- 0886US12252540B2Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Mar 18, 2025·1 cites·5 claims
- 0986US11059908B2Low-viscosity antigen binding proteins and methods of making themAMGEN INC·Filed 2017·Granted Jul 13, 2021·3 cites·9 claims
- 1086US11046774B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 1185US11248043B2Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereofAMGEN INC·Filed 2020·Granted Feb 15, 2022·1 cites·33 claims
- 1281US2024301087A1Anti-steap1 antigen-binding proteinAMGEN INC·Filed 2024·Application pending·0 cites
- 1381US2024150448A1Pac1 antibodies and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1479US10431325B2Methods to identify amino acid residues involved in macromolecular binding and uses thereforNOVARTIS AG·Filed 2013·Granted Oct 1, 2019·1 cites·17 claims
- 1577US2024343832A1Low-viscosity antigen binding proteins and methods of making themAMGEN INC·Filed 2024·Application pending·0 cites
- 1677US2024327486A1Interleukin-2 muteins for the expansion of t-regulatory cellsAMGEN INC·Filed 2024·Application pending·0 cites
- 1776US2023159656A1Anti-steap1 antigen-binding proteinAMGEN INC·Filed 2022·Application pending·0 cites
- 1874US9777067B2HER2- and VEGF-A-binding proteins with enhanced stabilityMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Oct 3, 2017·2 cites·15 claims
- 1971US11993663B2Low-viscosity antigen binding proteins and methods of making themAMGEN INC·Filed 2021·Granted May 28, 2024·0 cites·12 claims
- 2071US2025353899A1Engineering monoclonal antibodies to improve stability and production titerAMGEN INC·Filed 2025·Application pending·0 cites
- 2171US2025376529A1Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 2269US2025154281A1Anti-steap1 antigen-binding proteinAMGEN INC·Filed 2025·Application pending·0 cites
- 2368US2023381276A1Interleukin-21 mutein/ anti-pd-1 antibody conjugatesAMGEN INC·Filed 2022·Application pending·0 cites
- 2467US11976103B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2020·Granted May 7, 2024·0 cites·15 claims
- 2559US10762980B2Computer-implemented methods of determining protein viscosityMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted Sep 1, 2020·0 cites·12 claims
- 2656US2022144920A1Engineering monoclonal antibodies to improve stability and production titerAMGEN INC·Filed 2020·Application pending·0 cites
- 2755US12384849B2Bispecific antibodies with cleavable C-terminal charge-paired tagsAMGEN INC·Filed 2019·Granted Aug 12, 2025·0 cites·13 claims
- 2855US12103979B2N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptidesAMGEN INC·Filed 2018·Granted Oct 1, 2024·0 cites·23 claims
- 2950US2025197518A1Bispecific antibodies with cleavable c-terminal charge-paired tagsAMGEN INC·Filed 2025·Application pending·0 cites
- 3049US2022363770A1Anti-cgrp receptor/anti-pac1 receptor bispecific antigen binding proteinsAMGEN INC·Filed 2020·Application pending·0 cites
- 3142US2015239977A1Cd20- and egfr-binding proteins with enhanced stabilityMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 3240US2017114127A1Vegf-a-binding proteins and her2-binding proteins with enhanced stability against aggregationMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neeraj Jagdish Agrawal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →